Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Stevens-Johnson Syndrome | 8 | 2019 | 129 | 1.24 | Why? |
| Fasciitis, Necrotizing | 2 | 2017 | 56 | 0.81 | Why? |
| Soft Tissue Infections | 2 | 2018 | 116 | 0.76 | Why? |
| Phenobarbital | 1 | 2017 | 22 | 0.72 | Why? |
| Clostridium septicum | 1 | 2017 | 1 | 0.72 | Why? |
| Gas Gangrene | 1 | 2017 | 8 | 0.72 | Why? |
| Ear, External | 1 | 2017 | 19 | 0.69 | Why? |
| Fluoroquinolones | 2 | 2018 | 235 | 0.64 | Why? |
| Streptococcus pyogenes | 1 | 2017 | 118 | 0.63 | Why? |
| Angina Pectoris | 1 | 2017 | 114 | 0.63 | Why? |
| Bundle-Branch Block | 1 | 2017 | 127 | 0.62 | Why? |
| Legionnaires' Disease | 1 | 2017 | 108 | 0.60 | Why? |
| Coronary Occlusion | 1 | 2017 | 138 | 0.58 | Why? |
| Purpura Fulminans | 3 | 2019 | 22 | 0.57 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.54 | Why? |
| Renal Replacement Therapy | 3 | 2018 | 1530 | 0.54 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.53 | Why? |
| Bronchial Diseases | 1 | 2013 | 31 | 0.52 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.52 | Why? |
| Pneumonia, Bacterial | 2 | 2017 | 843 | 0.50 | Why? |
| Autoantibodies | 2 | 2021 | 2094 | 0.49 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.46 | Why? |
| Interferon Type I | 2 | 2021 | 2789 | 0.43 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.41 | Why? |
| Skin | 5 | 2019 | 2096 | 0.40 | Why? |
| Immune System Diseases | 1 | 2013 | 410 | 0.37 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.36 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 1454 | 0.33 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.30 | Why? |
| Shock, Septic | 4 | 2018 | 1313 | 0.28 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.27 | Why? |
| Necrosis | 2 | 2017 | 532 | 0.27 | Why? |
| Antiphospholipid Syndrome | 2 | 2021 | 533 | 0.26 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.25 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.24 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.24 | Why? |
| Positive-Pressure Respiration | 2 | 2020 | 1160 | 0.24 | Why? |
| Intensive Care Units | 10 | 2020 | 29594 | 0.23 | Why? |
| Anti-Bacterial Agents | 4 | 2018 | 10083 | 0.22 | Why? |
| Hemorrhage | 1 | 2013 | 3013 | 0.21 | Why? |
| Myocarditis | 1 | 2016 | 2731 | 0.21 | Why? |
| Shock, Cardiogenic | 2 | 2017 | 700 | 0.20 | Why? |
| Catastrophic Illness | 1 | 2019 | 41 | 0.20 | Why? |
| Respiratory Mechanics | 2 | 2020 | 585 | 0.19 | Why? |
| Re-Epithelialization | 1 | 2018 | 29 | 0.18 | Why? |
| Neuraminidase | 1 | 2020 | 289 | 0.18 | Why? |
| Tomography, Emission-Computed | 1 | 2017 | 27 | 0.18 | Why? |
| Antidotes | 1 | 2017 | 46 | 0.18 | Why? |
| Charcoal | 1 | 2017 | 55 | 0.17 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.17 | Why? |
| Meningococcal Infections | 2 | 2018 | 216 | 0.17 | Why? |
| Dermatomycoses | 1 | 2018 | 55 | 0.17 | Why? |
| France | 8 | 2020 | 12074 | 0.17 | Why? |
| Bronchoalveolar Lavage | 1 | 2021 | 603 | 0.17 | Why? |
| Drug Hypersensitivity Syndrome | 1 | 2018 | 74 | 0.16 | Why? |
| Dermatitis, Irritant | 1 | 2018 | 99 | 0.16 | Why? |
| Acute Chest Syndrome | 1 | 2017 | 140 | 0.16 | Why? |
| Nail Diseases | 1 | 2019 | 142 | 0.16 | Why? |
| Oseltamivir | 1 | 2020 | 583 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.15 | Why? |
| Life Support Care | 1 | 2017 | 161 | 0.15 | Why? |
| Amiodarone | 1 | 2017 | 110 | 0.15 | Why? |
| Fatal Outcome | 4 | 2018 | 3438 | 0.15 | Why? |
| Th17 Cells | 1 | 2021 | 657 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Middle Aged | 29 | 2021 | 270681 | 0.15 | Why? |
| Adenovirus Infections, Human | 1 | 2016 | 145 | 0.14 | Why? |
| Poisoning | 1 | 2017 | 176 | 0.14 | Why? |
| Metagenomics | 1 | 2021 | 823 | 0.14 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.14 | Why? |
| Aged | 19 | 2021 | 215776 | 0.14 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.14 | Why? |
| Electric Countershock | 1 | 2017 | 284 | 0.14 | Why? |
| Antibodies, Antiphospholipid | 1 | 2019 | 519 | 0.14 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.14 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.14 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.13 | Why? |
| Drug Resistance, Viral | 1 | 2020 | 1083 | 0.13 | Why? |
| Clinical Deterioration | 1 | 2018 | 473 | 0.13 | Why? |
| Adult | 21 | 2021 | 244371 | 0.13 | Why? |
| Female | 29 | 2021 | 380317 | 0.13 | Why? |
| Male | 27 | 2021 | 367725 | 0.13 | Why? |
| Humans | 44 | 2021 | 930598 | 0.13 | Why? |
| Hypotension | 1 | 2016 | 392 | 0.13 | Why? |
| Diagnostic Techniques, Respiratory System | 1 | 2013 | 114 | 0.12 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2020 | 861 | 0.12 | Why? |
| Exanthema | 1 | 2021 | 1097 | 0.11 | Why? |
| Hemoglobins | 2 | 2017 | 958 | 0.11 | Why? |
| Renal Insufficiency | 1 | 2018 | 810 | 0.11 | Why? |
| Anemia, Sickle Cell | 1 | 2017 | 546 | 0.10 | Why? |
| Pulmonary Artery | 1 | 2017 | 803 | 0.10 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.10 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.10 | Why? |
| Retrospective Studies | 14 | 2020 | 105322 | 0.09 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.09 | Why? |
| Mucormycosis | 1 | 2018 | 832 | 0.09 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.09 | Why? |
| Biopsy | 2 | 2017 | 2811 | 0.09 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.09 | Why? |
| Pulmonary Alveoli | 1 | 2013 | 867 | 0.09 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.09 | Why? |
| Eye Diseases | 1 | 2019 | 1150 | 0.09 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Steroids | 1 | 2013 | 904 | 0.08 | Why? |
| Debridement | 2 | 2018 | 172 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Acute Kidney Injury | 2 | 2018 | 5762 | 0.08 | Why? |
| Pharmaceutical Preparations | 1 | 2021 | 1897 | 0.08 | Why? |
| Stroke Volume | 1 | 2016 | 2153 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Neisseria meningitidis | 2 | 2018 | 229 | 0.08 | Why? |
| Time-to-Treatment | 2 | 2020 | 5883 | 0.07 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.07 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.06 | Why? |
| Electrocardiography | 1 | 2017 | 3957 | 0.06 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.06 | Why? |
| Receptors, Interleukin-8B | 1 | 2021 | 36 | 0.06 | Why? |
| Quality of Life | 2 | 2019 | 9820 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Organ Dysfunction Scores | 2 | 2018 | 1475 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.05 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.05 | Why? |
| Critical Care | 3 | 2018 | 14081 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.05 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.05 | Why? |
| Sclera | 1 | 2019 | 31 | 0.05 | Why? |
| International Classification of Functioning, Disability and Health | 1 | 2018 | 11 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| Hospital Mortality | 3 | 2018 | 22087 | 0.05 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.05 | Why? |
| Kidney | 1 | 2013 | 3648 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| CD28 Antigens | 1 | 2018 | 39 | 0.05 | Why? |
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2018 | 72 | 0.05 | Why? |
| Embolectomy | 1 | 2018 | 101 | 0.05 | Why? |
| Diagnosis, Differential | 1 | 2013 | 7220 | 0.05 | Why? |
| Electric Impedance | 1 | 2020 | 283 | 0.05 | Why? |
| Contact Lenses | 1 | 2019 | 108 | 0.04 | Why? |
| Prognosis | 5 | 2019 | 32490 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Hypokinesia | 1 | 2017 | 52 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Immunocompetence | 1 | 2018 | 280 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Connective Tissue Diseases | 1 | 2018 | 187 | 0.04 | Why? |
| Antibodies, Antinuclear | 1 | 2018 | 234 | 0.04 | Why? |
| Hospitals, Private | 1 | 2017 | 198 | 0.04 | Why? |
| Mental Disorders | 1 | 2019 | 6742 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.04 | Why? |
| Amputation | 1 | 2018 | 331 | 0.04 | Why? |
| Pneumonia, Mycoplasma | 1 | 2018 | 292 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2016 | 7301 | 0.04 | Why? |
| Follow-Up Studies | 3 | 2019 | 17020 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| APACHE | 1 | 2017 | 682 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Pharmacovigilance | 1 | 2018 | 501 | 0.03 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Prednisone | 1 | 2018 | 652 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2020 | 634 | 0.03 | Why? |
| Urine | 1 | 2016 | 469 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Superinfection | 1 | 2018 | 459 | 0.03 | Why? |
| Bronchoscopy | 1 | 2021 | 991 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2019 | 865 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.03 | Why? |
| Sensitivity and Specificity | 1 | 2013 | 22971 | 0.03 | Why? |
| Allergens | 1 | 2018 | 728 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Hospitals, Public | 1 | 2017 | 774 | 0.03 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.03 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.03 | Why? |
| Carbon Dioxide | 1 | 2017 | 917 | 0.03 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.03 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.02 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.02 | Why? |
| Immunoglobulins, Intravenous | 1 | 2018 | 2705 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.02 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Risk Assessment | 2 | 2018 | 25439 | 0.02 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.01 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2018 | 12447 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| China | 1 | 2018 | 50654 | 0.01 | Why? |
de Prost's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(316)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_